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Emerging disease in Africa
R. Colebunders
University of Antwerp, Antwerp, Belgium
Nodding syndrome (NS) is an unexplained neurological illness
that so far has been reported in onchocerciasis endemic areas in
South Sudan, northernUganda and Tanzania (Mahenge). NSmainly
occurs in children between 5 and 15 years of age. The syndrome
starts with involuntary nodding of the head in a previously healthy
child. As the disease progresses different types of epileptic seizures
occur, in some children accompanied by gradual cognitive dete-
rioration. Some children present with stunted growth without
secondary sexual characteristics.
Although the aetiology of NS is unknown, case control studies
suggested an associationbetweenNSandonchocerciasis. However,
PCR tests in cerebrospinal ﬂuids of NS patients failed to identify the
parasite’s DNA. We hypothesise that NS is caused by an unknown
neurotropic virus transmitted by the blackﬂy.
In certain villages in the West Equatorial state in South Sudan
one in 6 children has NS andmore than 50% of families have at least
one childwithNS. The prevalence of NS in these villages is about 8%
and new cases are still seen every month. In northern Uganda the
prevalence of NS is around 0.8%. In 2012 insecticides and larvicides
were used targeting the rivers where blackﬂies were breeding. As
a consequence, since 2013 no new cases of NS were reported. In
the past NS outbreaks appeared when populations moved into an
uninhabited forest andepidemicsdisappearedafter theuseof aerial
spraying or larviciding.
The “NS virus” may cause the classical NS symptoms but also
epilepsy and is probably responsible for the high prevalence of
epilepsy, also in other onchocerciasis endemic areas e.g. in Camer-
oun and the DRC
Insecticide spraying and use of larvicides, but not the use of
ivermectin, seems to be associated with a decrease of in the num-
ber of new NS cases. If conﬁrmed, our hypothesis will enable new
strategies to control NS outbreaks.
http://dx.doi.org/10.1016/j.ijid.2014.03.429
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The geography of infectious diseases in Africa:
From endemic populations to travelers
M. Mendelson
University of Cape Town, Cape Town, South Africa
The geography of infectious diseases in Africa is largely dictated
by vector distribution, daily activities that result in risk exposures,
such as immersion in inland waterways, sexual exposures or activ-
ities at the animal-human interface, and migration of pathogens
with their human hosts particularly during times of political con-
ﬂict. Malaria, HIV and tuberculosis dominate much of Africa’s
endemic burden of disease. However, as international attention
continues to focus on these epidemics, it also persists in side lining
important neglected tropical diseases and has failed to appreciate
developing epidemics on the continent, such as bacterial antibiotic
resistance.
The common misconception that travel to Africa presents a
homogenous risk in terms of acquisition of infections, prevents
an accurate, focused pre-travel consultation from taking place,
and under-appreciates the true differential diagnosis of fever in
returning travelers from different parts of the continent. Our
recent analysis of illnesses in travelers returning from Africa, who
attended one of the 54 international GeoSentinel Travel Surveil-
lance Network clinics over the past 14 years, has shown marked
regional variation in infections acquired in Africa. This paper will
elucidate the major divide between the types of illness acquired in
Northern and sub-SaharanAfrica, aswell asmajor differences in the
proportion of travelers who acquire different febrile illnesses such
as malaria, rickettsioses, schistosomiasis and dengue, depending
on the region to which they have traveled.
http://dx.doi.org/10.1016/j.ijid.2014.03.430
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Why are people still dying of HIV in Africa?
G. Meintjes
University of Cape Town, Cape Town, South Africa
The World Health Organisation (WHO) estimates that in 2012
there were 25.0 million people living with HIV infection in sub-
Saharan Africa. Antiretroviral therapy (ART) provision has been
dramatically scaled-up in countries across Africa over the last 10
years through government and donor initiatives: it is estimated
that 7.0 million adults in sub-Saharan Africa had started ART
by the end of 2012, representing 68% of those eligible by 2010
WHO criteria. However, HIV-related mortality in Africa remains
